Delivery Order SPE2DB22D2214-SPE2DB25FS3PX
Award Date
1/30/25
Potential Completion Date
1/31/25
Potential Value
$4K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Insulin Degludec Pen (U-200) 3ML. The $2,155.23 delivery order is a firm fixed-price contract with a completion date of July 25, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,190.14 firm fixed-price contract is for the supply of Insulin Degludec Pen (U-200) 3ML, a specialty medication used for diabetes management. The contract is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that Amerisourcebergen holds with the DLA Troop Support Medical, which serves...
This federal contract award, with the ID SPE2DB22D1202|SPE2DB25FUPB1, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,471.35 firm-fixed-price delivery order is for the supply of INSULIN DEGLUDEC PEN (U-200) 3ML, with a performance period ending on January 8, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a...
The Defense Logistics Agency (DLA) has awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $3,930.60 firm fixed price delivery order contract for the supply of insulin degludec pens (U-200, 3ML). This delivery order is placed under an indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary contract vehicle for Amerisourcebergen Drug Corp to deliver...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,733.88 firm fixed price delivery order is for the procurement of Insulin Degludec Pen (U-200) 3ML, which is a specialty medication used for diabetes management. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA Troop Support...
This federal contract award, valued at $1,071.99, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of INSULIN DEGLUDEC PEN (U-200) 3ML, a pharmaceutical product, with a period of performance through June 26, 2024. AmerisourceBergen, one of the largest pharmaceutical distribution companies, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to...
The U.S. Department of Defense (DOD) has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,184,917 units of Insulin Degludec Pens (U-200) 3ML. The contract, valued at $4,137.57, has an ultimate completion date of April 8, 2024. AmerisourceBergen Drug Corp is the prime contractor on this delivery order, which is issued under a larger $999,999,999.00 indefinite delivery contract (IDC) awarded by the...
This is a $2,042.47 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the supply of Insulin Degludec Pens (U-100) 3ML, a critical medical product used to manage diabetes. AmerisourceBergen, a major pharmaceutical distribution company, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999.00 through December 2025. This...
This federal contract award to Amerisourcebergen Drug Corp is a Delivery Order valued at $1,313.56 for the supply of Insulin Degludec Pen (U-200) 3ML. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major defense agency. This award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999, that enables the agency to efficiently procure a comprehensive range of pharmaceutical and medical supplies...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of insulin degludec pens (U-200, 3 mL). The contract has a ceiling value of $4,417.19 and a completion date of January 2, 2025. It is a Firm Fixed Price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA...